From Rs 4.3 crore to Rs 20 crore: EOW steps in as HDFC loan scam widens; accused used forged salary slips, bank statements
HYDERABAD: The scope of the
HDFC Bank
personal loan fraud has significantly widened, prompting the police commissioner to transfer the case from the cyber crime police to the economic offences wing (EOW).
Initially involving fraudulent loans worth Rs 4.3 crore in the names of 11 individuals, the case has widened after HDFC Bank unearthed 63 more suspicious loans-allegedly orchestrated with the involvement of bank staff-amounting to over Rs 20 crore.
HDFC Bank has provided the names and details of the 63 individuals linked to the Rs 20 crore worth of loans.
You Can Also Check:
Hyderabad AQI
|
Weather in Hyderabad
|
Bank Holidays in Hyderabad
|
Public Holidays in Hyderabad
The scam first came to light on May 27, 2023, when V Shrikanth, area investigation manager at HDFC Bank, lodged a complaint with the Cyberabad cyber crime police.
He alleged that 11 individuals, falsely posing as employees of reputed companies, had secured personal loans ranging between Rs 38 lakh and Rs 49.5 lakh in 2022-2023. These applications were processed entirely via the bank's mobile platform using Aadhaar-based e-KYC.
To qualify for the loans, the accused allegedly uploaded forged salary slips, bank statements, and identity proofs, giving the impression of stable incomes.
'Defaulted payments'
Once the loans were disbursed, the borrowers defaulted on payments and vacated the listed addresses. Subsequent verification visits confirmed that none of them worked at the companies they had claimed. On June 10, 2023, police arrested 10 accused, including two HDFC Bank employees D Chitti Babu, risk intelligence and control (RIC) manager at the Banjara Hills branch, and Harish Chandra Gopal Shetty, credit manager in the same branch.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
20 minutes ago
- Economic Times
Singapore International Arbitration Centre rules in favour of Amazon in Future Group case
Amazon claim trimmed Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The Singapore International Arbitration Centre (SIAC) has ruled in favour of Amazon in its long-standing legal battle with Kishore Biyani-led Future Group , holding that Reliance Retail- Future merger deal breached its pre-existing contract. However, Amazon has managed to get minuscule damages of Rs 23.7 crore against claimed amount of Rs 1436 a final award issued late Thursday night, the three-member tribunal said the 2020 board resolution by Future Retail Ltd (FRL) approving the sale of its retail, wholesale, and logistics assets to Reliance was in breach of contractual obligations under the Shareholders' Agreement (SHA) and Share Subscription Agreement (SSA) signed between Amazon and Future Coupons Pvt Ltd (FCPL).While Amazon had sought damages of Rs 1,436 crore, the tribunal awarded a significantly smaller sum of Rs 23.7 crore. It directed 11 promoters and parties, including Kishore Biyani , to jointly and severally pay the amount, along with interest at 10.3% annually (compounded) from March 9, 2022, until full payment. The parties are also liable to bear Amazon's arbitration and litigation tribunal noted that 835 of FRL's 1,534 retail stores were transferred in a manner that breached Amazon's contractual rights stemming from its 2019 acquisition of 49% in FCPL for Rs 1,400 crore. FCPL held a 10% stake in Tribunal held that Amazon was entitled to damages due to the promoters' repudiatory breaches of the Future Coupons Pvt Ltd (FCPL) Shareholders' Agreement (SHA), but it rejected the quantum of Rs 1,436 crore claimed by the had based its claim on "reliance loss," arguing that it should be compensated for the full value of its 2019 investment in FCPL including Rs 1,430 crore paid under the Share Subscription Agreement and Rs 5 crore in associated the Tribunal found that even if all contractual agreements had been fully performed, Amazon would not have recovered its entire investment due to the declining financial condition of Future Retail Ltd (FRL) the ultimate beneficiary of Amazon's stake in the impact of the COVID-19 pandemic and FRL's deteriorating business value, the Tribunal observed that awarding full damages would unfairly shield Amazon from a commercial loss it was likely to incur regardless.'Such an award would essentially allow Amazon to escape a bad bargain,' the final award the Tribunal awarded Amazon total legal and related costs of Rs 77.3 crore and SGD 68, Amazon-Future legal dispute began in October 2020, when SIAC's emergency arbitrator restrained Future Retail from proceeding with the Reliance deal. The Future Group had challenged the arbitration, citing the Competition Commission of India's 2022 suspension of the Amazon-FCPL deal.
Indian Express
29 minutes ago
- Indian Express
Delhi drugs control department cracks down on sale of fake cholesterol medicines
The Delhi drugs control department recently uncovered a multi-level distribution network involved in the sale and circulation of spurious Rosuvas F 20 tablets, a prescription drug used to manage cholesterol and triglyceride levels, officials said on Friday. The action followed a complaint from Sun Pharmaceutical Industries Ltd, which reported that fake versions of its Rosuvas F 20 tablets were being sold by a retail outlet in central Delhi. The complaint mentioned a multi-level supply chain involving multiple wholesalers and distributors across the city. Rosuvas F 20 is a fixed-dose combination drug containing Rosuvastatin (20 mg) and Fenofibrate (160 mg). It is commonly prescribed to patients who require medication to manage high cholesterol and triglyceride levels, especially when lifestyle changes alone are not sufficient. The drug plays a vital role in preventing serious cardiovascular conditions such as heart attacks and strokes. Drugs control department officials said Rosuvas F 20 tablets were a fast-moving drug, and on June 14 and 15, 1,800 spurious tablets worth Rs 88,000 were seized from two locations in Okhla and Bhagirath Palace. 'On June 14, we first received a complaint from Rajinder Nagar, but no stock was found. A link was established in Okhla and Bhagirath Palace, where raids were conducted,' an official said. Officials noted irregularities and a suspicious absence of genuine stock at several distribution points, which ultimately led them to a firm located in the Okhla Industrial Area. 'Visual inspection and comparison with authentic samples suggested that the seized products were spurious — their appearance and packaging did not match those of the legitimate manufacturer,' said an official. Here, additional suspect stock of Rosuvas F 20 was found. Legal samples were collected from Bhagirath Palace, Chandni Chowk—one of Delhi's busiest medicine markets—and sent to a government laboratory for quality testing, while manufacturer verification is also underway, officials revealed. The department has secured custody permission for the seized drugs through the Delhi High Court. 'We are now coordinating with authorities in other states to trace the full supply chain behind the fake medication,' the official said.
Time of India
31 minutes ago
- Time of India
$1.86 billion worth of IPO shares set to unlock in July: Nuvama Report
A significant volume of pre-IPO shareholder lock-ins worth $ 1,860 million is set to expire in July 2025, potentially reshaping the shareholding structure of several recently listed companies . According to a report by domestic brokerage Nuvama Institutional Equities, the lock-in expiries next month span across multiple companies and include both promoter and non-promoter holdings. The expiring shares cover both one-month and six-month lock-in tenures. While these shares will become eligible for trading, the report notes that not all will necessarily be sold in the open market, as a considerable portion may continue to be held by promoters and strategic long-term investors. Under the one-month lock-in category, three companies are scheduled to see their restricted shares unlock in July. Scoda Tubes , with a lock-in value of $ 5 million, will unlock on 2nd July. Arisinfra Solutions follows with $ 10 million worth of shares becoming tradable on 23rd July, and Oswal Pumps will unlock shares worth $ 27 million on 18th July. The total lock-in value under the one-month category is $ 42 million. In the six-month lock-in segment, six companies are expected to see significantly larger expiries. Unimech Aerospace & Manufacturing leads with a lock-in value of $ 501 million, unlocking on 1st July. Standard Glass Lining Tech. will see $ 259 million worth of shares unlock on 11th July, followed by Quadrant Future Tek with $ 123 million on 14th July. Laxmi Dental is scheduled for $ 105 million worth of unlocks on 21st July. Live Events Indo Farm Equipment will witness two separate unlock events: $ 51 million worth of shares on 10th July, and an additional $ 2 million on 11th July, taking the combined total to $ 53 million. The lock-in expiries in July also include other companies such as RBZ Jewellers ($ 14 million), Vraj Iron & Steel ($ 37 million), Medi Assist Healthcare ($ 82 million), Jyoti CNC Automation ($ 598 million), and Sanstar Limited ($ 46 million). While these companies are set for unlocks in July, Nuvama's broader lock-in analysis covers a total of 57 companies between 30th June and 30th October 2025, with an aggregate lock-in value of $ 15 billion. The study includes companies listed up to 25th June 2025. Such expiries are closely watched by market participants, as they can lead to changes in liquidity, free float, and shareholding patterns in the post-IPO phase. Also read: Rs 1 lakh crore selloff tsunami threatens Nifty rally as promoters, strategic investors exit ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
